Related Experiment Video
Updated: Apr 15, 2026

Assembly and Purification of Prototype Foamy Virus Intasomes
Published on: March 19, 2018
Human Pirh2 is a novel inhibitor of prototype foamy virus replication
Lanlan Dong1,2, Qingqing Cheng3, Zhihao Wang4
1Pathogenic Organism and Infectious Diseases Research Institute, School of Basic Medical Sciences, Wuhan University, Donghu Road No. 185, Wuchang, Wuhan 430071, China. donglanlan.2006@163.com.
Abstract:
Prototype foamy virus (PFV) is a member of the unconventional and nonpathogenic retroviruses. PFV causes lifelong chronic infections, which are partially attributable to a number of host cell factors that restrict viral replication. Herein, we identified human p53-induced RING-H2 protein (Pirh2) as a novel inhibitor of prototype foamy virus. Overexpression of Pirh2 decreased the replication of PFV, whereas knockdown of Pirh2 with specific siRNA increased PFV replication. Dual-luciferase assays and coimmunoprecipitation demonstrated that Pirh2 negatively influences the Tas-dependent transcriptional activation of the PFV long terminal repeat (LTR) and internal promoter (IP) by interacting with the transactivator Tas and down-regulating its expression. In addition, the viral inhibitory function of Pirh2 is N-terminal and RING domain dependent. Together, these results indicated that Pirh2 suppresses PFV replication by negatively impacting its transactivator Tas and the transcription of two viral promoters, which may contribute to the latency of PFV infection.
Insights
Human Pirh2 protein inhibits prototype foamy virus (PFV) replication by targeting its transactivator Tas. This discovery offers insights into controlling chronic retroviral infections and PFV latency.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Prototype foamy virus (PFV) is a nonpathogenic retrovirus causing chronic infections.
- Host cell factors play a role in restricting PFV replication.
- Understanding host-viral interactions is crucial for managing persistent infections.
Purpose of the Study:
- To identify novel host factors that inhibit prototype foamy virus (PFV) replication.
- To elucidate the mechanism by which Pirh2 suppresses PFV.
- To explore the role of Pirh2 in the latency of PFV infection.
Main Methods:
- Overexpression and siRNA-mediated knockdown of human p53-induced RING-H2 protein (Pirh2).
- Assessment of PFV replication levels.
- Dual-luciferase assays and coimmunoprecipitation to study protein interactions and transcriptional activity.
Main Results:
- Pirh2 was identified as a novel inhibitor of PFV replication.
- Pirh2 overexpression decreased PFV replication, while Pirh2 knockdown increased it.
- Pirh2 interacts with the PFV transactivator Tas, down-regulating its expression and activity, thereby suppressing viral transcription from PFV LTR and IP promoters.
Conclusions:
- Pirh2 suppresses PFV replication by inhibiting the Tas transactivator and viral promoter transcription.
- The inhibitory function of Pirh2 depends on its N-terminal and RING domains.
- Pirh2's role in suppressing PFV replication may contribute to the establishment and maintenance of PFV latency.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
07:50Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase
Published on: December 8, 2017
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Bacterial Protein Synthesis
Viruses with RNA Genomes
Retroviruses
Retrovirus Life Cycles